After finishing at $2.77 in the prior trading day, Aldeyra Therapeutics Inc (NASDAQ: ALDX) closed at $2.79, up 0.72%. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 809183 shares were traded.
Ratios:
Our goal is to gain a better understanding of ALDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.00.
On February 08, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $26.
On December 16, 2020, Berenberg started tracking the stock assigning a Buy rating and target price of $32.Berenberg initiated its Buy rating on December 16, 2020, with a $32 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’24 when Brady Todd C sold 85,324 shares for $3.05 per share. The transaction valued at 260,238 led to the insider holds 1,471,298 shares of the business.
Machatha Stephen sold 11,537 shares of ALDX for $36,503 on Mar 12 ’24. The Chief Development Officer now owns 243,495 shares after completing the transaction at $3.16 per share. On Mar 11 ’24, another insider, Brady Todd C, who serves as the President and CEO of the company, sold 97,914 shares for $3.27 each. As a result, the insider received 320,521 and left with 1,556,622 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 164.91M and an Enterprise Value of 37.74M.
Stock Price History:
Over the past 52 weeks, ALDX has reached a high of $11.97, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 3.3453, while the 200-Day Moving Average is calculated to be 5.2433.
Shares Statistics:
The stock has traded on average 843.86K shares per day over the past 3-months and 623.77k shares per day over the last 10 days, according to various share statistics. A total of 59.20M shares are outstanding, with a floating share count of 56.55M. Insiders hold about 3.98% of the company’s shares, while institutions hold 59.55% stake in the company. Shares short for ALDX as of Feb 29, 2024 were 1.94M with a Short Ratio of 2.30, compared to 2.01M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.28% and a Short% of Float of 4.16%.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of $0.02 and a low estimate of -$0.21, while EPS last year was -$0.27. The consensus estimate for the next quarter is $0.11, with high estimates of $1.35 and low estimates of -$0.17.
Analysts are recommending an EPS of between $1.77 and -$0.72 for the fiscal current year, implying an average EPS of $0.08. EPS for the following year is -$0.36, with 4 analysts recommending between $0.55 and -$0.8.
Revenue Estimates
Based on 4 analysts’ estimates, the company’s revenue will be $51.71M in the next fiscal year. The high estimate is $100M and the low estimate is $18.7M. The average revenue growth estimate for next year is up 106.80% from the average revenue estimate for this year.
